Location History:
- Kraainem, BE (1999)
- Krazinem, BE (2003)
- Brussels, BE (2003 - 2004)
- Basel, CH (2008)
Company Filing History:
4 out of 525 
1 out of 93 
1 out of 832,891 Years Active: 1999-2008
Title: The Innovative Contributions of Guy R Cornelis
Introduction
Guy R Cornelis is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly in the isolation of cytotoxic T lymphocyte (CTL) clones. With a total of 5 patents, his work has advanced the understanding of tumor antigens and their potential applications in medical treatments.
Latest Patents
One of his latest patents focuses on tumor antigens and CTL clones isolated by a novel procedure. This invention relates to the isolation of CTL clones that are specific for proteins of the MAGE family. The process involves successive steps of stimulation and testing of lymphocytes with antigen-presenting cells that present antigens derived from various expression systems. Additionally, he has developed nucleic acid molecules encoding antigenic peptides from MAGE molecules that bind to HLA. An example of such a nucleic acid molecule is one coding for the peptide GVYDGREHTV, which binds to HLA-A2. These innovations are crucial for diagnosing and treating various pathological conditions.
Career Highlights
Throughout his career, Guy R Cornelis has worked with prestigious organizations, including the Ludwig Institute for Cancer Research Limited and Université Catholique de Louvain. His research has been instrumental in advancing cancer immunotherapy and understanding the immune response to tumors.
Collaborations
He has collaborated with notable colleagues such as Thierry R Boon-Falleur and Pascal Chaux, contributing to a rich exchange of ideas and advancements in their field.
Conclusion
Guy R Cornelis's innovative work in the field of cancer research has led to significant advancements in the understanding of tumor antigens and CTL clones. His contributions continue to impact the medical community and offer hope for improved diagnostic and therapeutic strategies.